European Laryngological Society consensus statement on optimal monitoring schedules after treatment for early glottic cancer: a risk-stratification

Early glottic cancer has an excellent prognosis provided that recurrences are detected in a timely manner. However, current guidelines lack specific recommendations for intervals or interventions during follow-up, and primarily advocate surveillance in the most advanced stages where the benefits are actually the lowest. This consensus statement introduces a risk-stratification-guided follow-up schedule for T1-T2N0 patients, aiming to optimize oncologic and functional outcomes while ensuring early detection of residual or recurrent disease to preserve organ function. Separate protocols are outlined for surgical and non-surgical patients, including endoscopic examination, radiological imaging, and thyroid function screening. Also, the pathway to reach this routine observation phase is described, specifying the criteria and timing of a second-look microlaryngoscopy.

Authors

Institutions

Publication Details

Journal
European Archives of Oto-Rhino-Laryngology
Published
2025-08-04
DOI
https://doi.org/10.1007/s00405-025-09609-0
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

European Laryngological Society consensus statement on optimal monitoring schedules after treatment for early glottic cancer: a risk-stratification

Cesare Piazza, Berit M. Verbist, Giovanni Succo, Małgorzata Wierzbicka et al.
European Archives of Oto-Rhino-Laryngology
Head and Neck Cancer Studies
article

European Laryngological Society consensus statement on optimal monitoring schedules after treatment for early glottic cancer: a risk-stratification

Cesare Piazza, Berit M. Verbist, Giovanni Succo, Małgorzata Wierzbicka, Martine Hendriksma, Elisabeth V. Sjögren, Ricard Simó, Davide Farina, Marco Lionello, Marc Remacle, Andy Bertolin, Agatha Baidun
article en

Abstract

Early glottic cancer has an excellent prognosis provided that recurrences are detected in a timely manner. However, current guidelines lack specific recommendations for intervals or interventions during follow-up, and primarily advocate surveillance in the most advanced stages where the benefits are actually the lowest. This consensus statement introduces a risk-stratification-guided follow-up schedule for T1-T2N0 patients, aiming to optimize oncologic and functional outcomes while ensuring early detection of residual or recurrent disease to preserve organ function. Separate protocols are outlined for surgical and non-surgical patients, including endoscopic examination, radiological imaging, and thyroid function screening. Also, the pathway to reach this routine observation phase is described, specifying the criteria and timing of a second-look microlaryngoscopy.

European Archives of Oto-Rhino-LaryngologyVol. 282(9)
Wrocław University of Science and Technology (PL), Centre Hospitalier de Luxembourg (LU), Guy's and St Thomas' NHS Foundation Trust (GB), Leiden University Medical Center (NL), Surgical Specialties (Canada) (CA), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), Ospedale San Giovanni Bosco (IT), Institute of Plant Genetics, Polish Academy of Sciences (PL), Ospedale Civile di Vittorio Veneto (IT), AGH University of Krakow (PL), University of Brescia (IT)
Good health and well-being
Openalex Percentile: Top 73%
Head and Neck Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.